Trial · NCT01162122
Results by group283
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 283
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 1 | H1N1 strain (N=1072,1078,1075) | 209 | 95% Confidence Interval 189 to 231 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 2 | H1N1 strain (N=1072,1078,1075) | 187 | 95% Confidence Interval 170 to 207 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 3 | H1N1 strain (N=1072,1078,1075) | 199 | 95% Confidence Interval 180 to 220 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 1 | H3N2 strain (N=1072,1078,1075) | 548 | 95% Confidence Interval 502 to 598 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 2 | H3N2 strain (N=1072,1078,1075) | 542 | 95% Confidence Interval 498 to 591 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 3 | H3N2 strain (N=1072,1078,1075) | 556 | 95% Confidence Interval 510 to 606 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 1 | B strain | 56 | 95% Confidence Interval 51 to 61 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 2 | B strain | 56 | 95% Confidence Interval 51 to 61 | Titers |
| Geometric Mean Titers in Subjects After Receiving One Dose of Lot 1 or Lot 2 or Lot 3 of aTIV | aTIV_Lot 3 | B strain | 58 | 95% Confidence Interval 53 to 64 | Titers |
| Comparison of aTIV Versus TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains - PPS | aTIV (Pooled) | H1N1 strain (N=3225,3257) | 198 | 95% Confidence Interval 185 to 211 | Titers |
| Comparison of aTIV Versus TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains - PPS | Licensed TIV | H1N1 strain (N=3225,3257) | 141 | 95% Confidence Interval 132 to 150 | Titers |
| Comparison of aTIV Versus TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains - PPS | aTIV (Pooled) | H3N2 strain (N=3225,3256) | 544 | 95% Confidence Interval 513 to 575 | Titers |
| Comparison of aTIV Versus TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains - PPS | Licensed TIV | H3N2 strain (N=3225,3256) | 337 | 95% Confidence Interval 319 to 357 | Titers |
| Comparison of aTIV Versus TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains - PPS | aTIV (Pooled) | B strain | 55 | 95% Confidence Interval 52 to 58 | Titers |
| Comparison of aTIV Versus TIV in Terms of Geometric Mean Titers (GMTs) Against Homologous Strains - PPS | Licensed TIV | B strain | 48 | 95% Confidence Interval 46 to 51 | Titers |
| Comparison of aTIV Versus TIV in Terms of Percentage of Subjects Achieving Seroconversion Against Homologous Strains-PPS | aTIV (Pooled) | H1N1 strain (N=3225,3257) | 77.4 | 95% Confidence Interval 75.9 to 78.9 | Percentage of subjects |
| Comparison of aTIV Versus TIV in Terms of Percentage of Subjects Achieving Seroconversion Against Homologous Strains-PPS | Licensed TIV | H1N1 strain (N=3225,3257) | 67.6 | 95% Confidence Interval 65.9 to 69.2 | Percentage of subjects |
| Comparison of aTIV Versus TIV in Terms of Percentage of Subjects Achieving Seroconversion Against Homologous Strains-PPS | aTIV (Pooled) | H3N2 strain (N=3225,3256) | 74.0 | 95% Confidence Interval 72.4 to 75.5 | Percentage of subjects |
| Comparison of aTIV Versus TIV in Terms of Percentage of Subjects Achieving Seroconversion Against Homologous Strains-PPS | Licensed TIV | H3N2 strain (N=3225,3256) | 60.7 | 95% Confidence Interval 59.0 to 62.3 | Percentage of subjects |
| Comparison of aTIV Versus TIV in Terms of Percentage of Subjects Achieving Seroconversion Against Homologous Strains-PPS | aTIV (Pooled) | B strain | 47.0 | 95% Confidence Interval 45.2 to 48.7 | Percentage of subjects |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01162122/results